Morgan Stanley analyst Michael Ulz downgraded Taysha Gene Therapies to Equal Weight from Overweight with a $3 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TSHA:
Morgan Stanley analyst Michael Ulz downgraded Taysha Gene Therapies to Equal Weight from Overweight with a $3 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TSHA: